Strata Skin Sciences, Inc.
SSKN
$2.89
$0.2911.15%
| Weiss Ratings | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.88 | |||
| Price History | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 9.47% | |||
| 30-Day Total Return | 1.76% | |||
| 60-Day Total Return | -4.62% | |||
| 90-Day Total Return | -8.98% | |||
| Year to Date Total Return | -0.69% | |||
| 1-Year Total Return | -44.42% | |||
| 2-Year Total Return | -68.92% | |||
| 3-Year Total Return | -80.21% | |||
| 5-Year Total Return | -77.06% | |||
| 52-Week High % Change | -56.67% | |||
| 52-Week Low % Change | 3.59% | |||
| Price | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $6.00 | |||
| 52-Week Low Price | $2.51 | |||
| 52-Week Low Price (Date) | Mar 07, 2025 | |||
| 52-Week High Price (Date) | Mar 12, 2024 | |||
| Valuation | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.85M | |||
| Enterprise Value | 20.26M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.60 | |||
| Earnings Per Share Growth | 25.88% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.32 | |||
| Price/Book (Q) | 1.16 | |||
| Enterprise Value/Revenue (TTM) | 0.62 | |||
| Price | $2.89 | |||
| Enterprise Value/EBITDA (TTM) | -17.35 | |||
| Enterprise Value/EBIT | -3.28 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.04M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 215 619 3200 | |||
| Address | 5 Walnut Grove Drive Horsham, PA 19044 | |||
| Website | www.strataskinsciences.com | |||
| Country | United States | |||
| Year Founded | 1989 | |||
| Profitability | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -18.92% | |||
| Profit Margin | -28.71% | |||
| Management Effectiveness | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -8.85% | |||
| Return on Equity | -- | |||
| Income Statement | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 32.68M | |||
| Total Revenue (TTM) | 32.68M | |||
| Revenue Per Share | $8.09 | |||
| Gross Profit (TTM) | 18.13M | |||
| EBITDA (TTM) | -1.17M | |||
| EBIT (TTM) | -6.19M | |||
| Net Income (TTM) | -9.38M | |||
| Net Income Avl. to Common (TTM) | -9.38M | |||
| Total Revenue Growth (Q YOY) | -0.62% | |||
| Earnings Growth (Q YOY) | -101.52% | |||
| EPS Diluted (TTM) | -2.60 | |||
| EPS Diluted Growth (Q YOY) | -74.20% | |||
| Balance Sheet | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 7.06M | |||
| Cash Per Share (Q) | $1.75 | |||
| Total Current Assets (Q) | 15.88M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 9.34M | |||
| Current Ratio (Q) | 1.131 | |||
| Book Value Per Share (Q) | $2.24 | |||
| Total Assets (Q) | 40.21M | |||
| Total Current Liabilities (Q) | 14.05M | |||
| Total Debt (Q) | 16.48M | |||
| Total Liabilities (Q) | 30.86M | |||
| Total Common Equity (Q) | 9.34M | |||
| Cash Flow | SSKN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.99M | |||
| Cash from Financing (TTM) | 1.93M | |||
| Net Change in Cash (TTM) | -69.00K | |||
| Levered Free Cash Flow (TTM) | 3.79M | |||
| Cash from Operations (TTM) | 991.00K | |||
